The global demand for Gliclazide Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period 2021 - 2027.
Gliclazide is a sulfonylurea type of anti-diabetic medication used to treat diabetes mellitus type 2. It is consumed orally. Gliclazide is used to control hyperglycemia in gliclazide-responsive diabetes mellitus of stable, mild, non-ketosis prone, type 2 diabetes. It is used when diabetes cannot be controlled by proper dietary management and exercise or when insulin therapy is inappropriate. Gliclazide lowers blood sugar by increasing the amount of insulin the body produces.
The growth of this market can be attributed to the rise in the prevalence of type 2 diabetes globally. As per NCBI, the prevalence is likely to reach 330 MN cases by 2022. Further, advancement in diabetic drugs by pharmaceutical manufacturers propel the growth of the market. In addition to this, rising awareness, massive research funding in diabetes diagnosis and treatment, and unmet medical needs drive market growth. Other factors such as the rising obese population, government initiative, improving regulatory framework, and growing consumption rate are consistently encouraging the sales of the product. However, the associated risk of side effects may restrict the market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of gliclazide.
This section of the primaquine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
This section covers the regional outlook, which accentuates current and future demand for the Primaquine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Gliclazide Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gliclazide market include Discovery Fine Chemicals, CarboMer, HBCChem, Ivy Fine Chemicals, Clearsynth, Bal Pharma, Fengchen Group, Sinopharm, Hairuichem and Dayang chem. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.